New drug tested to quiet debilitating cough in serious lung disease
Symptom relief
Completed
This study tested whether a drug called orvepitant could reduce the severity and frequency of chronic cough in people with idiopathic pulmonary fibrosis (IPF), a serious scarring lung disease. In this completed Phase 2 trial, 80 participants tried both the study drug and a placeb…
Phase: PHASE2 • Sponsor: Nerre Therapeutics Ltd. • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC